What does Silodosin (Rapaflo) do in plain English—and how does it work inside your body?
Silodosin is an FDA-regulated alpha-Adrenergic Blocker (RxNorm RxCUI 809477). Mechanistically, 12.1 Mechanism of Action Silodosin is a selective antagonist of post-synaptic alpha-1 adrenoreceptors, which are located in the human prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra. Blockade of these alpha-1 adrenoreceptors can cause smooth muscle in these tissues to relax, resulting in an improvement in urine flow and a reduction in BPH symptoms. An in vitro study examining binding affinity of silodosin to the three subtypes of the alpha-1 adrenoreceptors (alpha-1A, alpha-1B, and alpha-1D) was conducted. [1][2].
When your doctor writes a prescription for Silodosin (RxNorm RxCUI 809477, also dispensed under brand names including Rapaflo), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action Silodosin is a selective antagonist of post-synaptic alpha-1 adrenoreceptors, which are located in the human prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra. Blockade of these alpha-1 adrenoreceptors can cause smooth muscle in these tissues to relax, resulting in an improvement in urine flow and a reduction in BPH symptoms. An in vitro study examining binding affinity of silodosin to the three subtypes of the alpha-1 adrenoreceptors (alpha-1A, alpha-1B, and alpha-1D) was conducted. [2].
Across real-world patient logs on dotMD (80% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Silodosin tablet bottle and confirm with your pharmacist that it matches your prescribed strength (4 mg/1 Capsule, 8 mg/1 Capsule, 4mg Capsule, 8mg Capsule).